Artificial IntelligenceCapeStart Debuts MadeAi™, its GenAI-enabled Platform for Life Sciences that Transforms Literature Review and other Applications
At the ISPOR Europe 2024 Conference today, CapeStart, Inc. debuted MadeAi™—a generative AI-based platform that dramatically streamlines the synthesis of clinical information—with its first solution, MadeAi-LR. Supporting literature review, MadeAi-LR unlocks efficiency for systematic literature reviews (SLRs), clinical evidence reports (CERs), meta research, targeted literature reviews (TLRs), and other clinical literature assessments. “PhD researchers and highly credentialed life science experts should spend their time on achieving breakthroughs in health, not consumed by mundane tasks that can be offloaded...